Skip to content
Contact Us
Careers
About Aerpio
Management
Board of Directors
Advisory Board
Tie2 Pathway
The Basics
VE-PTP and Ang-2
Pipeline
AKB-9778
ARP-1536
AKB-4924
Clinical Trials
Therapeutic Areas
Diabetic Retinopathy
Wet AMD / DME
IBD
Investors
Publications
Advancing first-in-class treatments targeting
the Tie2 pathway for ocular diseases
Aiming to stabilize vasculature in the most
common retinopathies
With an innovative approach that may represent
the most efficient way to restore Tie2 activation
Home
About Aerpio
ABOUT TIE2 – VE PTP